Elevated plasma soluble LOX-1 level is the major modifiable risk factor for ischemic heart disease and could be considered as a suitable diagnostic biomarker for acute myocardial infarction patients but further larger clinical studies are required. This evidence concerns the gene OLR1 and coronary artery disorder.